4.6 Review

Relative Risk of Bladder and Kidney Cancer in Lynch Syndrome: Systematic Review and Meta-Analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Review Urology & Nephrology

Immunohistochemical Screening of Upper Tract Urothelial Carcinomas for Lynch Syndrome Diagnostics: A Systematic Review

Maria Rasmussen et al.

Summary: After reviewing 12 studies, it was found that universal screening for MMR protein loss in UTUC may lead to Lynch syndrome diagnoses in 4.7% of patients, highlighting the importance of follow-up investigations for genetic testing.

UROLOGY (2022)

Review Urology & Nephrology

Genitourinary manifestations of Lynch syndrome in the urological practice

Chiara Lonati et al.

Summary: This study provides a comprehensive overview of the genitourinary manifestations of Lynch syndrome (LS), focusing on the incidence, diagnosis, clinical features, therapeutic strategies, and screening protocols. Upper tract urothelial carcinoma (UTUC) is the most common cancer in the urological field among LS patients. The diagnosis of LS among UTUC patients is a step-by-step process involving clinical criteria, molecular testing, and genetic testing. The European Association of Urology (EAU) guidelines recommend molecular testing for specific groups of UTUC patients. Multidisciplinary management is important for newly diagnosed LS patients. Further research is needed to determine the role of LS in bladder cancer, prostate cancer, and renal cell carcinoma.

ASIAN JOURNAL OF UROLOGY (2022)

Review Oncology

Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology-Young Academic Urologists and the Global Society of Rare Genitourinary Tumors

Chiara Lonati et al.

Summary: This article provides a systematic review of upper tract urothelial carcinoma (UTUC) among patients with Lynch syndrome (LS), covering incidence, diagnosis, clinicopathological features, oncological outcomes, and screening protocols. LS patients have a significantly increased risk of UTUC compared to the general population, and they tend to be diagnosed at a younger age. Comprehensive management including multidisciplinary teams and genetic counseling should be implemented for the diagnosis and treatment of LS patients.

EUROPEAN UROLOGY ONCOLOGY (2022)

Review Urology & Nephrology

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

Morgan Roupret et al.

Summary: The updated EAU guidelines on UTUC aim to assist clinicians in evidence-based management, providing recommendations on diagnosis, risk stratification, radical and conservative treatment, and prognostic factors. Due to the rarity of UTUC, there is insufficient data to provide strong recommendations. Recommendations are based on the 2017 TNM classification and emphasize individualized treatment based on proposed risk stratification.

EUROPEAN UROLOGY (2021)

Article Cell Biology

Identifying mismatch repair-deficient colon cancer: near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based series

Maurice B. Loughrey et al.

Summary: This study compared PCR-based microsatellite instability (MSI) testing and MMR protein immunohistochemistry (IHC) in colorectal cancer cases and found that both methods are equally proficient in establishing MMR/MSI status, but awareness of potential pitfalls is important. The choice of methodology may depend on available services and expertise.

HISTOPATHOLOGY (2021)

Article Biochemical Research Methods

MSIsensor-ct: microsatellite instability detection using cfDNA sequencing data

Xinyin Han et al.

Summary: MSIsensor-ct is a bioinformatics tool based on a machine learning protocol for detecting MSI status using cfDNA sequencing data, with a potential stable MSIscore threshold of 20%. Evaluation on independent testing datasets with various levels of ctDNA and sequencing depth showed 100% accuracy within the limit of detection of 0.05% ctDNA content. MSIsensor-ct requires only BAM files as input, making it user-friendly and easily integrated into NGS analysis pipelines.

BRIEFINGS IN BIOINFORMATICS (2021)

Article Biochemistry & Molecular Biology

NGS-based identification and tracing of microsatellite instability from minute amounts DNA using inter-Alu-PCR

Fangyan Yu et al.

Summary: Sensitive detection of microsatellite instability (MSI) using next generation sequencing (NGS) is increasingly important in cancer prognosis and prediction. A new approach combining inter-Alu-PCR with targeted NGS offers a practical and efficient method for detecting MSI, with the potential to trace low-level MSI in tissue or liquid biopsies.

NUCLEIC ACIDS RESEARCH (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Biochemistry & Molecular Biology

Sensitive detection of microsatellite instability in tissues and liquid biopsies: Recent developments and updates

Fangyan Yu et al.

Summary: Microsatellite instability (MSI) has significant applications in cancer, with sensitive detection methods developed for MSI classification. There is growing interest in minimally-invasive MSI detection through liquid biopsy samples.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Review Gastroenterology & Hepatology

An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome

Christina Therkildsen et al.

Summary: Immune checkpoint-based therapy has shown high efficacy in MSI tumors including Lynch syndrome, which is associated with MMR deficiency and an immune-infiltrative microenvironment. While Lynch syndrome patients may benefit from this treatment, differences exist in molecular characteristics and treatment responses between Lynch syndrome and sporadic MSI tumors.

CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2021)

Article Oncology

Clinical Factors Associated with Urinary Tract Cancer in Individuals with Lynch Syndrome

Jonathan W. Wischhusen et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)

Review Oncology

Microsatellite instability: a review of what the oncologist should know

Kai Li et al.

CANCER CELL INTERNATIONAL (2020)

Article Medical Laboratory Technology

High-Accuracy Determination of Microsatellite Instability Compatible with Liquid Biopsies

Amanda Bortolini Silveira et al.

CLINICAL CHEMISTRY (2020)

Review Urology & Nephrology

Lynch Syndrome in Urologic Malignancies - What Does the Urologist Need to Know?

Hanan Goldberg et al.

UROLOGY (2019)

Article Multidisciplinary Sciences

Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling

Brian D. Robinson et al.

NATURE COMMUNICATIONS (2019)

Article Oncology

Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy

Aaron M. Goodman et al.

CANCER IMMUNOLOGY RESEARCH (2019)

Article Oncology

Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer

Alicia Latham et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Article Urology & Nephrology

Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma

Michael J. Metcalfe et al.

JOURNAL OF UROLOGY (2018)

Article Oncology

Molecular subtype classification of urothelial carcinoma in Lynch syndrome

Christina Therkildsen et al.

MOLECULAR ONCOLOGY (2018)

Article Health Care Sciences & Services

Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation

Tristan Snowsill et al.

HEALTH TECHNOLOGY ASSESSMENT (2017)

Article Oncology

Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch Syndrome

N. Jewel Samadder et al.

JAMA ONCOLOGY (2017)

Review Urology & Nephrology

Lynch syndrome in upper tract urothelial carcinoma: significance, screening, and surveillance

Benjamin Pradere et al.

CURRENT OPINION IN UROLOGY (2017)

Review Toxicology

Microsatellite instability: an update

Hiroyuki Yamamoto et al.

ARCHIVES OF TOXICOLOGY (2015)

Review Urology & Nephrology

Lynch Syndrome: A Primer for Urologists and Panel Recommendations

Maureen Mork et al.

JOURNAL OF UROLOGY (2015)

Article Biochemical Research Methods

MSIsensor: microsatellite instability detection using paired tumor-normal sequence data

Beifang Niu et al.

BIOINFORMATICS (2014)

Review Oncology

Risk of Prostate Cancer in Lynch Syndrome: A Systematic Review and Meta-analysis

Shae Ryan et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)

Article Pathology

Microsatellite Instability and TARBP2 Mutation Study in Upper Urinary Tract Urothelial Carcinoma

Shuting Bai et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)

Article Oncology

The spectrum of urological malignancy in Lynch syndrome

P. J. Barrow et al.

FAMILIAL CANCER (2013)

Article Oncology

The History of Lynch Syndrome

C. Richard Boland et al.

FAMILIAL CANCER (2013)

Article Medicine, General & Internal

Stratifying Risk of Urinary Tract Malignant Tumors in Patients With Asymptomatic Microscopic Hematuria

Ronald K. Loo et al.

MAYO CLINIC PROCEEDINGS (2013)

Article Oncology

Uroepithelial and kidney carcinoma in Lynch syndrome

Markku Aarnio et al.

FAMILIAL CANCER (2012)

Article Oncology

Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome

Christoph Engel et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

Article Urology & Nephrology

Urinary tract cancer in patients with hereditary non-polyposis colorectal cancer

Peter Zachhau et al.

SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2012)

Article Medicine, General & Internal

Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer A Cost-Effectiveness Analysis

Uri Ladabaum et al.

ANNALS OF INTERNAL MEDICINE (2011)

Article Health Care Sciences & Services

GRADE guidelines: 7. Rating the quality of evidence-inconsistency

Gordon H. Guyatt et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Article Health Care Sciences & Services

GRADE guidelines: 3. Rating the quality of evidence

Howard Balshem et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Article Health Care Sciences & Services

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

Gordon Guyatt et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Article Health Care Sciences & Services

GRADE guidelines 6. Rating the quality of evidence-imprecision

Gordon H. Guyatt et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Article Urology & Nephrology

Upper Urinary Tract Carcinoma in Lynch Syndrome Cases

David G. Crockett et al.

JOURNAL OF UROLOGY (2011)

Review Oncology

Management of extracolonic tumours in patients with Lynch syndrome

Jan J. Koornstra et al.

LANCET ONCOLOGY (2009)

Article Oncology

The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome

Patrice Watson et al.

INTERNATIONAL JOURNAL OF CANCER (2008)

Article Pathology

DNA degradation test predicts success in whole-genome amplification from diverse clinical samples

Fengfei Wang et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2007)

Article Oncology

Who should be sent for genetic testing in hereditary colorectal cancer syndromes?

Henry T. Lynch et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

Review Biochemistry & Molecular Biology

Mechanisms in eukaryotic mismatch repair

Paul Modrich

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Medicine, General & Internal

Prediction of germline mutations and cancer risk in the Lynch syndrome

Sining Chen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

Review Medicine, General & Internal

Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome - A systematic review

Noralane M. Lindor et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

Article Gastroenterology & Hepatology

Decrease in mortality in Lynch syndrome families because of surveillance

AE De Jong et al.

GASTROENTEROLOGY (2006)

Review Urology & Nephrology

Microsatellite instability and transitional cell carcinoma of the upper urinary tract

M Roupret et al.

BJU INTERNATIONAL (2005)

Article Biotechnology & Applied Microbiology

Development of a fluorescent multiplex assay for detection of MSI-high tumors

JW Bacher et al.

DISEASE MARKERS (2004)

Article Medicine, General & Internal

Measuring inconsistency in meta-analyses

JPT Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)

Article Pathology

Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction

KD Berg et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2000)